Repare Therapeutics Files 8-K Amendment
| Field | Detail |
|---|---|
| Company | Repare Therapeutics Inc. |
| Form Type | 8-K/A |
| Filed Date | Jun 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, filing-amendment, executive-compensation
TL;DR
Repare Therapeutics filed an 8-K amendment regarding leadership changes and compensation.
AI Summary
Repare Therapeutics Inc. filed an amendment (8-K/A) on June 2, 2025, to its Form 8-K dated March 31, 2025. This amendment pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements for certain officers. The filing does not provide specific names or dollar amounts related to these changes.
Why It Matters
This filing indicates potential changes in the company's leadership or executive compensation structure, which could impact its strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Amendments to 8-K filings concerning officer and director changes can signal internal shifts that may affect company strategy and performance.
Key Players & Entities
- Repare Therapeutics Inc. (company) — Registrant
FAQ
What specific event triggered the original Form 8-K filing on March 31, 2025?
The filing does not specify the exact event that triggered the original Form 8-K, only that the amendment pertains to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers'.
What are the key changes detailed in this 8-K/A amendment?
The amendment relates to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, but specific details are not provided in the excerpt.
When was the amendment filed with the SEC?
The amendment (8-K/A) was filed as of date June 2, 2025.
What is Repare Therapeutics Inc.'s principal executive office address?
The principal executive offices are located at 7171 Frederick-Banting, Building 2, Suite 270, St-Laurent, Québec, Canada, H4S 1Z9.
What is the SIC code for Repare Therapeutics Inc.?
The Standard Industrial Classification (SIC) code for Repare Therapeutics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on June 2, 2025 regarding Repare Therapeutics Inc..